Merck & Co. (after 2009)

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Schering-Plough
gptkbp:acquisitionYear 2009
gptkbp:alsoKnownAs MSD outside the United States and Canada
gptkbp:CEO gptkb:Robert_M._Davis
gptkbp:country gptkb:United_States
gptkbp:divested 2021
Organon & Co.
gptkbp:ESRB_rating gptkb:A_(MSCI,_2023)
gptkbp:founded 1891
gptkbp:founder gptkb:George_Merck
gptkbp:headquartersLocation gptkb:Kenilworth,_New_Jersey,_United_States
https://www.w3.org/2000/01/rdf-schema#label Merck & Co. (after 2009)
gptkbp:industry pharmaceuticals
gptkbp:legalForm gptkb:public_company
gptkbp:mainFieldOfActivity gptkb:diabetes
animal health
infectious diseases
oncology
vaccines
vaccine development
cardiovascular diseases
pharmaceutical research
animal health products
gptkbp:marketCap over $250 billion (2023)
gptkbp:notable_executive gptkb:Robert_M._Davis
gptkb:Kenneth_C._Frazier
Roger M. Perlmutter
gptkbp:notableCase gptkb:Vioxx_litigation
gptkbp:notableInvention Gardasil patent
Keytruda patent
gptkbp:notableProduct gptkb:Gardasil
gptkb:Isentress
gptkb:Januvia
gptkb:Keytruda
gptkb:Singulair
gptkbp:numberOfEmployees ~69,000 (2023)
gptkbp:parentCompany none (independent)
gptkbp:predecessor Merck & Co. (before 2009)
gptkbp:publiclyTraded NYSE: MRK
gptkbp:relatedOrganization gptkb:Merck_KGaA
gptkbp:revenue $59.3 billion (2023)
gptkbp:servesArea worldwide
gptkbp:slogan Inventing for Life
gptkbp:stockExchange gptkb:Dow_Jones_Industrial_Average
gptkb:S&P_500
gptkb:S&P_100
gptkbp:stockSymbol gptkb:MRK
gptkbp:subsidiary gptkb:Merck_Research_Laboratories
gptkb:Merck_Animal_Health
gptkbp:website https://www.merck.com/
gptkbp:bfsParent gptkb:Schering-Plough_(2009)
gptkbp:bfsLayer 6